Intracellular drug delivery by sulfatide-mediated liposomes to gliomas

This publication has 25 references indexed in Scilit:

• Recent advances with liposomes as pharmaceutical carriers
  Nature Reviews Drug Discovery, 2005
• Tenascins: regulation and putative functions during pathological stress
  The Journal of Pathology, 2003
• Ligand-targeted therapeutics in anticancer therapy
  Nature Reviews Cancer, 2002
• Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
  Journal of Neurochemistry, 2002
• Preferential Binding of Polyethylene Glycol-Coated Liposomes Containing a Novel Cationic Lipid, TRX-20, to Human Subendthelial Cells via Chondroitin Sulfate
  Pharmaceutical Research, 2001
• Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in Vivo
  Journal of Biological Chemistry, 1998
• Liposome-Mediated Therapy of Intracranial Brain Tumors in a Rat Model
  Pharmaceutical Research, 1997
• Evidence for the role of proteoglycans in cation-mediated gene transfer.
  Proceedings of the National Academy of Sciences, 1996
• Metabolic and functional aspects of sulfogalactolipids
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
• In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1992